Triggered C-reactive protein (CRP) concentrations and the CRP gene -717A>G polymorphism in acute stroke or transient ischemic attack

European Journal of Neurology

Volumn 14, Issue 3, 2007, Pages 315-320

  Ben Assayag, E ^a,b   Shenhar Tsarfaty, S ^a,b   Bova, I ^a,b   Berliner, S ^a,b   Shopin, L ^a,b   Peretz, H ^a,b   Usher, S ^a,b   Shapira, I ^a,b   Bornstein, N M ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

C reactive protein; Inflammation; Polymorphism; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRANSIENT ISCHEMIC ATTACK;

ACUTE DISEASE; AGED; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; UP-REGULATION;

EID: 33847729456     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01661.x     Document Type: Article

References (22)

1. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Current Problem Cardiology 2004; 29: 439-493.
2. Chamorro A. Role of inflammation in stroke and atherothrombosis. Cerebrovascular Diseases 2004; 17(Suppl.3): 1-5.
3. Castellanos M, Castillo J, Garcia MM et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002; 33: 982-987.
4. Christensen H, Boysen G. C-reactive protein and white blood cell count increases in the first 24 h after acute stroke. Cerebrovascular Diseases 2004; 18: 214-219.
5. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002; 33: 2459-2464.
6. Kovacs A, Green F, Hansson LO et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 2005; 178: 193-198.
7. Suk HJ, Ridker PM, Cook NR, Zee RY. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 2005; 178: 139-145.
8. Brull DJ, Serrano N, Zito F et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2003; 23: 2063-2069.
9. Adams HP Jr, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicentre clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
10. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clinical Chemistry 1999; 45: 2136-2141.
11. Chen J, Zhao J, Huang J, Su S, Qiang B, Gu D. -717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study. Journal of Molecular Medicine 2005; 83: 72-78.
12. Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002; 162: 217-219.
13. Szalai AJ, McCrory MA, Cooper GS, Wu J, Kimberly RP. Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene. Genes Immunity 2002; 3: 14-19.
14. Wolford JK, Gruber JD, Ossowski VM et al. A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Molecular Genetics Metabolism 2003; 78: 136-144.
15. Zee RY, Hegener HH, Cook NR, Ridker PM. C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis. Journal of Thrombosis Haemostasis 2004; 2: 1240-1243.
16. Zee RY, Hegener HH, Fernandez-Cruz A, Lindpaintner K. C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis. Atherosclerosis 2004; 176: 393-396.
17. Araujo F, Pereira AC, Mota GF, Latorre MR, Krieger JE, Mansur AJ. The influence of tumor necrosis factor - 308 and C-reactive protein G1059C gene variants on serum concentration of C-reactive protein: evidence for an age-dependent association. Clinica Chimica Acta 2004; 349: 129-134.
18. de Maat MP, Bladbjerg EM, Hjelmborg JB, Bathum L, Jespersen J, Christensen K. Genetic influence on inflammation variables in the elderly. Arteriosclerosis, Thrombosis and Vascular Biology 2004; 24: 2168-2173.
19. Flex A, Pola R, Serricchio M et al. Polymorphisms of the macrophage inhibitory factor and C-reactive protein genes in subjects with Alzheimer's dementia. Dementia and Geriatric Cognitive Disorders 2004; 18: 261-264.
20. Smith GD, Lawlor DA, Harbord R et al. Association of C-reactive protein with blood pressure and hypertension. Life course confounding and mendelian randomization tests of causality. Arteriosclerosis, Thrombosis, and Vascular Biology 2005; 25: 1051-1056.
21. Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj J. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2001; 103: 1933-1935.
22. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003; 34: 2922-2929.